First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
FBT Stock Price Chart Interactive Chart >
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $171.33 | 52-week high | $186.51 |
| Prev. close | $174.05 | 52-week low | $149.58 |
| Day low | $170.34 | Volume | 29,844 |
| Day high | $172.93 | Avg. volume | 60,851 |
| 50-day MA | $170.67 | Dividend yield | 0.00001% |
| 200-day MA | $168.91 |
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.92B |
| Net Asset Value (NAV) | $174.14 |
| Options? | Yes |
| Total Holdings | 32 |
FBT Top Holdings
| Symbol | Company | % of Total |
| BNTX | BioNTech SE | 5.13% |
| MRNA | Moderna Inc | 4.9% |
| SRPT | Sarepta Therapeutics Inc | 4.07% |
| ALKS | ALKERMES PLC | 4.01% |
| EXEL | EXELIXIS INC | 3.9% |
| TECH | BIOTECHNE CORP | 3.68% |
| QGEN | QIAGEN NV | 3.65% |
| CRL | Charles River Laboratories International Inc | 3.63% |
| RARE | Ultragenyx Pharmaceutical Inc | 3.6% |
| REGN | Regeneron Pharmaceuticals Inc | 3.56% |
FBT Price Returns
| 1-mo | 1.49% |
| 3-mo | -1.23% |
| 6-mo | 9.78% |
| 1-year | 8.96% |
| 3-year | 11.67% |
| 5-year | 68.14% |
| YTD | 1.99% |
| 2020 | 12.96% |
| 2019 | 19.74% |
| 2018 | -0.30% |
| 2017 | 37.07% |
| 2016 | -19.59% |
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||